SCHEDULE: Whitefort Capital Discloses 8.4% Stake in OmniAb
Beneficial Ownership Report
Whitefort Capital Management, LP and its Co-Managing Partners, David Salanic and Joseph Kaplan, have disclosed a passive 8.4% beneficial ownership stake in OmniAb, Inc.
Summary
- Whitefort Capital Management, LP, along with Co-Managing Partners David Salanic and Joseph Kaplan, collectively reported beneficial ownership of 10,240,146 shares of OmniAb, Inc. Common Stock.
- This ownership represents 8.4% of OmniAb, Inc.'s outstanding shares.
- The percentage is calculated based on 122,335,336 shares outstanding as of May 1, 2025, as reported in OmniAb's Form 10-Q filed on May 8, 2025.
- The filing is an Amendment No. 1 to a previous Schedule 13G.
- The Reporting Persons certified that the securities were not acquired and are not held for the purpose of changing or influencing the control of OmniAb, Inc.
Sentiment
Score: 5
Explanation: The filing is a standard beneficial ownership disclosure (Schedule 13G), indicating a passive investment without intent to influence control. This type of filing is generally neutral in sentiment regarding the company's operational or financial performance.
Future Outlook
This filing is a beneficial ownership report and does not contain forward-looking statements or guidance regarding OmniAb, Inc.'s operations or financial performance.
Industry Context
This filing indicates a significant passive investment by Whitefort Capital Management in OmniAb, Inc., a company operating in the biotechnology sector. Such disclosures are routine for institutional investors crossing beneficial ownership thresholds and do not inherently signal specific industry trends beyond general investment interest in the sector.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake may be viewed positively by some investors as a vote of confidence, while others may monitor for potential future changes in ownership or strategy, though the filing explicitly states a passive intent.
Key Dates
| Date | Description |
|---|---|
| 2025-05-01 | Date of OmniAb, Inc.'s shares outstanding calculation (122,335,336 shares) as reported in their Form 10-Q. |
| 2025-05-08 | Date OmniAb, Inc. filed its Form 10-Q with the SEC. |
| 2025-06-30 | Date of event which required the filing of this statement (beneficial ownership as of this date). |
| 2025-08-14 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
OmniAb Inc, Whitefort Capital Management, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Management, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.